The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The artificial intelligence (AI)-driven hospital readmission predictor market size has experienced significant growth in recent years. It is projected to expand from $1.92 billion in 2025 to $2.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 26.2%. This historical expansion can be attributed to the increasing adoption of AI in healthcare, a growing demand to reduce hospital readmissions, the rising availability of electronic health records, the expansion of predictive analytics usage, and an increasing focus on patient outcomes.

The artificial intelligence (AI)-driven hospital readmission predictor market size is expected to experience significant expansion over the next few years. It is anticipated to grow to $6.09 billion in 2030, achieving a compound annual growth rate (CAGR) of 25.9%. This growth in the forecast period can be attributed to factors such as increasing investments in healthcare IT infrastructure, the growing integration of clinical decision support systems, rising adoption of cloud-based analytics platforms, the expansion of remote patient monitoring tools, and a stronger emphasis on value-based care models. Key trends during this period include technological advancements in machine learning models, innovations in real-time patient monitoring, ongoing research and development in natural language processing, the creation of explainable AI for healthcare, and improvements in interoperable healthcare IT systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

What Primary Factors Are Fueling The Expansion Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

The rising incidence of chronic diseases is anticipated to fuel the expansion of the artificial intelligence (AI)-driven hospital readmission predictor market in the future. Chronic illnesses are enduring health conditions that typically develop gradually, such as diabetes, heart disease, and arthritis, often requiring continuous medical care and lifestyle adjustments to manage symptoms and avert complications. These conditions are primarily increasing due to detrimental lifestyle choices, including poor diet, lack of physical activity, and smoking, which elevate the likelihood of ailments such as diabetes, heart disease, and obesity. Artificial intelligence (AI)-driven hospital readmission predictors assist in managing chronic illnesses by examining patient data to identify individuals prone to readmission. They enhance patient outcomes by facilitating early interventions, tailored treatment strategies, and prompt monitoring to prevent issues and shorten inpatient periods. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Consequently, the growing prevalence of chronic diseases is propelling the growth of the artificial intelligence (AI)-driven hospital readmission predictor market.

How Does Segment Analysis Break Down The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Structure?

The artificial intelligence (AI)-driven hospital readmission predictor market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud

3) By Application: Patient Risk Assessment, Care Management, Clinical Decision Support, Population Health Management, Other Applications

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Software: Electronic Health Record Integration, Predictive Analytics Platforms, Risk Scoring Systems, Clinical Decision Support Tools

2) By Hardware: Servers, Sensors, Monitoring Devices, Data Storage Devices

3) By Services: Data Analytics Services, Predictive Modeling Services, Integration And Deployment Services, Training And Support Services, Monitoring And Reporting Services

What Trends Are Influencing The Future Of The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Companies active in the artificial intelligence (AI)-driven hospital readmission predictor market are concentrating on creating sophisticated solutions, including advanced predictive modeling, to identify patients at high risk, enable early interventions, and improve post-discharge care. Advanced predictive modeling entails utilizing complex statistical algorithms and machine learning techniques on historical and real-time data to discover intricate patterns and generate highly accurate forecasts of future outcomes. For instance, in July 2025, Innovaccer Inc., a US-based healthcare AI company, introduced its AI-Powered Readmissions Management Solution, which incorporates advanced predictive modeling to pinpoint avoidable readmissions among Medicare, Medicaid, and uninsured populations. The platform also offers comprehensive 360-degree patient views, agentic AI tools such as Care Management Copilot and Pre-Call Coordinator Agent for automating workflows, and benchmark intelligence for proactive intervention strategies. This solution aids healthcare providers in reducing readmission rates, optimizing resource allocation, and enhancing overall patient outcomes.

Who Are The Leading Firms Participating In The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

Major companies operating in the artificial intelligence (AI)-driven hospital readmission predictor market are Oracle Corporation, Siemens Healthineers AG, Cognizant Technology Solutions Corp., Epic Systems Corporation, SAS Institute Inc., Veradigm Inc., Merative LLP, Health Catalyst Inc., Lumeris Inc., Innovaccer Inc., Optum Inc., H2O.ai Inc., Healthfirst Inc., Qventus Inc., Lightbeam Health Solutions Inc., HealthEC LLC, Collective Medical Technologies Inc., CarePredict Inc., HBI Solutions Inc., CloudMedx

Access The Complete Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-driven-hospital-readmission-predictor-market-report

Which Region Is The Primary Market For The Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market?

North America was the largest region in the artificial intelligence (AI)-driven hospital readmission predictor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven hospital readmission predictor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Intelligence (AI)-Driven Hospital Readmission Predictor Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30521&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model